weekly-highlights
Cleveland's WNBA team doesn't play until 2028 but Progressive just scored jersey sponsorship | Fortune
Cleveland’s WNBA team doesn’t play its first game until May 2028. However, the framework is steadily…
Trump says 'we're gonna help' Lebanon as he moves to restore direct flights after four-decade hiatus | Fortune
PresidentDonald Trumppledged to helpLebanon“a lot” during a White House meeting on Tuesday with the country’s leader,…
U.N. reports Southeast Asia's criminal networks are using tech to build a global illicit economy | Fortune
Southeast Asia-based criminal groups are using increasingly integrated networks and technology to build a rapidly growing…
Seeds, schmear, sesame: How a bagel's toasted crunch that became a reflection of America's identity | Fortune
The bagel in America is an immigrant story with a hole in the middle. It came…
Anthropic to pay authors $1.5 billion over pirated books used to train Claude in first major AI copyright settlement | Fortune
A federal judge has approved a $1.5 billioncopyright settlementin which artificial intelligence company Anthropic will pay…
This Unsung Artificial Intelligence (AI) Hero Just Announced Incredible News. Is It Still a Buy? |
There are countless companies involved in the AI build-out, and a few of them fly under…
Why Is Walt Disney Stock So Much Cheaper Than Netflix? This Is the Only Answer I Can Think Of. |
Walt Disney (DIS +2.18%) shares have tumbled. They now trade 52% below their record from March…
I'm Officially Sounding the Alarm on GE Vernova: Here's What Investors Should Buy Instead |
Let me be clear up front: GE Vernova (GEV -1.59%) is a terrific business. Its power-generation…
The Smartest Way to Invest $5,000 in a Trillion-Dollar Stock Over Private Space Plays |
Space is one of the most exciting investing themes going, but the ways to play it…
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold — It's Backed by a Catalyst Many Investors Are Underrating |
If you’re keeping an eye on gene-editing specialist CRISPR Therapeutics (CRSP -2.08%), you probably already know…
English (United States) 
Chinese